Current Assets تغيير تاريخ
AbbVie USD 33.22B 4.37B 2023-09
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Amarin USD 717.51M 11.02M 2023-09
Amgen USD 30.33B 18.14B 2023-12
Biogen USD 6.86B 1.59B 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
CSL USD 9.26B 342.6M 2023-06
Cytokinetics USD 628.05M 66.63M 2023-12
Daiichi Sankyo JPY 1.52T 15.17B 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Esperion Therapeutics USD 218.23M 13.9M 2023-09
Geron USD 341.35M 6.26M 2023-12
Grifols EUR 5.02B 210.6M 2023-09
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Heron Therapeutics USD 193.98M 28.7M 2023-09
Intra Cellular Therapies USD 667.8M 34.63M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Merck USD 31.95B 1.98B 2023-09
Minerva Neurosciences USD 48.22M 4M 2023-09
Moderna USD 10.32B 474M 2023-12
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Pfizer USD 74.01B 665M 2023-09
PTC Therapeutics USD 1.22B 678.27M 2023-12
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
United Therapeutics USD 3.55B 92.1M 2023-12
Vanda Pharmaceuticals USD 533.5M 203K 2023-06



Esperion Therapeutics أصول متداولة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.